Ranked among the 5,000 newest matching findings; add words or filters to narrow the search.
The review found no eligible studies for this question.
Steroids (any route) showed no clear difference in clinical pregnancy rate compared with no steroids (or placebo) (low certainty).
The review found no eligible studies for this question.
Hydroflotation agents leads to lower incidence of adhesions at second‐look laparoscopy compared with no hydroflotation agents (or placebo) (high certainty).
Hydroflotation agents showed no clear difference in clinical pregnancy rate compared with no hydroflotation agents (or placebo) (moderate certainty).
The review found no eligible studies for this question.
The review found no eligible studies for this question.
The review found no eligible studies for this question.
Gel agents leads to lower incidence of adhesions at second‐look laparoscopy compared with no gel agents (or placebo) (high certainty).
Zonisamide probably leads to higher 50% responder rate (whole treatment period; any dose) compared with placebo (moderate certainty).
Zonisamide probably leads to higher withdrawal rates (whole treatment period; any dose) compared with placebo (moderate certainty).
Zonisamide may leads to higher adverse effects: ataxia (whole treatment period; any dose) compared with placebo (low certainty).
Zonisamide probably leads to higher adverse effects: dizziness (whole treatment period; any dose) compared with placebo (moderate certainty).
Zonisamide probably leads to higher adverse effects: fatigue (whole treatment period; any dose) compared with placebo (moderate certainty).
Zonisamide probably leads to higher adverse effects: nausea (whole treatment period; any dose) compared with placebo (moderate certainty).
Zonisamide probably leads to higher adverse effects: somnolence (whole treatment period; any dose) compared with placebo (moderate certainty).
Levetiracetam probably leads to higher 50% or greater reduction in focal seizure frequency (responders)… compared with placebo (moderate certainty).
Levetiracetam showed no clear difference in treatment withdrawal– all doses compared with placebo (high certainty).
Levetiracetam probably leads to higher adverse effects: 5 most common adverse effects (any age) – somnolence compared with placebo (moderate certainty).